FROM THE EDITORS DESK
Year : 2017 | Volume
: 12 | Issue : 2 | Page : 67-
From the Editor's desk
Editor-in-Chief, Indian Journal of Rheumatology
|How to cite this article:|
Ravindran V. From the Editor's desk.Indian J Rheumatol 2017;12:67-67
|How to cite this URL:|
Ravindran V. From the Editor's desk. Indian J Rheumatol [serial online] 2017 [cited 2021 Mar 4 ];12:67-67
Available from: https://www.indianjrheumatol.com/text.asp?2017/12/2/67/207146
Rheumatology in India like many other subspecialties in medical field is in constant need of rapidly adapting the advances in the field keeping in mind the uniqueness of the Indian scenario and due pragmatism on the face of limited resources. In this context, I would like to draw your attention to the topical review in this issue of the Journal by Durga et al., appraising the combination of conventional synthetic disease-modifying antirheumatic drugs in the management of rheumatoid arthritis vis a vis biologic disease-modifying antirheumatic drugs (pages 104-109). It underscores the need to develop India-specific guidelines for the management of rheumatic diseases which must confirm to and reflect the variable access to several therapeutic modalities across India.
I am pleased to share that your Journal is included in the list of the University Grants Commission (UGC)-approved list of journals for the purpose of Career Advancement Scheme and Direct Recruitment of Teachers and other academic staff as required under the UGC (Minimum Qualifications for Appointment of Teachers and other Academic Staff in Universities and Colleges) (please visit http://www.ugc.ac.in/ugc_notices.aspx?id=1604).
As ever, I welcome feedback or suggestions regarding any aspect of the Journal by mailing to [email protected] or to the postal address of the editorial office as appears below.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.